Lataa...
Sarcoma Immunotherapy: Past Approaches and Future Directions
Sarcomas are heterogeneous malignant tumors of mesenchymal origin characterized by more than 100 distinct subtypes. Unfortunately, 25–50% of patients treated with initial curative intent will develop metastatic disease. In the metastatic setting, chemotherapy rarely leads to complete and durable res...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3981453/ https://ncbi.nlm.nih.gov/pubmed/24778572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/391967 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|